Genomics research peering into the pathogenesis of adult de novo acute myeloid leukemia (AML) reveals many important relationships in both genomic and exomic mutations, according to a review published May 1 in the New England Journal of Medicine.

Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced an important milestone for its Phase 3 flurpiridaz F 18 clinical program.

Navidea Biopharmaceuticals, Inc. (NYSE MKT:  NAVB), a biopharmaceutical company focused on the development and commercialization of precision diagnostic radiopharmaceuticals, today announced the U.S. launch of Lymphoseek® (technetium Tc 99m tilmanocept) Injection for use in lymphatic mapping procedures that are performed to help in the diagnostic evaluation of potential cancer spread for patients with breast cancer and melanoma.

ZONARE Medical Systems, the pioneer and developer of next generation ultrasound technology, is experiencing significant growth in the expanding vascular healthcare market with several customers purchasing additional ZONARE systems to support practice growth.

While verbal memory decline associated with Alzheimer’s disease has been well documented, a similarly relevant area of research has gone relatively uncharted until now. Those affected by the neurodegenerative disease also suffer loss of nonverbal memory function and researchers are mapping the effects of Alzheimer’s disease on brain regions dedicated to this area of cognition and finding newly blazed trails of neural activity, according to a study published April 26 in Neurology.

The lay media often cast the screening mammo debate in black and white terms. It’s a disservice; breast imagers and physicians realize the issues are far more nuanced. Women’s right to screening is a highly emotionally charged issue, further complicating physicians’ attempts to educate women and often derailing stakeholders’ calls for targeted screening. Peggy Orenstein completed an incredibly detailed review of the risks and benefits of screening and treatment and the role of nonprofit marketing in an article published April 26 in The New York Times magazine. Check it out, and please consider sharing it.

For patients with non-small cell lung carcinoma, volumetric data derived from quantitative PET imaging could provide more precision staging and inform physicians about patient survival, according to a study published in the March issue of the American Journal of Roentgenology.

Today Siemens Healthcare celebrated the grand opening of its new state-of-the-art ultrasound systems factory in suburban Philadelphia. The 12,000 sq. ft. facility, located at 5168 Campus Drive in Plymouth Meeting, Pa., will manufacture Siemens’ new ACUSON Freestyle™ ultrasound system – the world’s first and only ultrasound system to feature wireless transducers.